MITORX THERAPEUTICS
MitoRx Therapeutics is a biotechnology company developing novel therapeutics that reverse mitochondrial dysfunction.
MITORX THERAPEUTICS
Social Links:
Industry:
Biotechnology Therapeutics
Founded:
2016-01-01
Address:
Harwell, Oxfordshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.mitorxtherapeutics.com
Status:
Active
Total Funding:
0
Current Employees Featured
Investors List
Oxford Technology Management
Oxford Technology Management investment in Seed Round - MitoRx Therapeutics
Longevitytech.fund
Longevitytech.fund investment in Seed Round - MitoRx Therapeutics
Science Angel Syndicate
Science Angel Syndicate investment in Seed Round - MitoRx Therapeutics
Wren Capital
Wren Capital investment in Seed Round - MitoRx Therapeutics
UK Innovation & Science Seed Fund
UK Innovation & Science Seed Fund investment in Seed Round - MitoRx Therapeutics
The Fink Family Office
The Fink Family Office investment in Seed Round - MitoRx Therapeutics
Official Site Inspections
http://www.mitorxtherapeutics.com Semrush global rank: 5.36 M Semrush visits lastest month: 1.56 K
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 99.83.190.102
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "MitoRx Therapeutics"
MitoRx Therapeutics - First-in-class mitochondrial protective …
Developing revolutionary mitochondrial-protective therapeutics which reverse mitochondrial dysfunction to arrest decline in muscular dystrophy and neurodegeneration. Mito Rx …See details»
MitoRx Therapeutics
MitoRx Therapeutics (MitoRx), a biotechnology company developing novel therapeutics that reverse mitochondrial dysfunction to arrest the progression of degenerative diseases, …See details»
MitoWorld
Based in Oxford and Exeter, UK, MitoRx is developing a pipeline of pre-clinical programs to progress to the clinic. Built around the pioneer of mitochondrial-targeted sulfide donor …See details»
MitoRx Therapeutics - LinkedIn
MitoRx Therapeutics is an Oxford based preclinical stage platform biotech developing mitochondrial-targeted small molecules that uniquely restore sulfide-signaling, a conserved system required...See details»
MitoRx Therapeutics Company Profile 2024: Valuation, …
Developer of mitochondrial-protective therapeutics designed to target neuromuscular disorders, metabolic disease, and dementia.See details»
MitoRx raises $5m to advance mitochondrial …
Dec 13, 2023 · British longevity biotech MitoRx Therapeutics has concluded a seed extension financing round, bringing total funding in the company to £4 million ($5 million). The company is developing medications to arrest the …See details»
MitoRx Therapeutics - VentureRadar
Website: https://www.mitorxtherapeutics.com/ Develops mitochondrial protective therapeutics targeting rare and broader diseases, utilizing proprietary technology to restore function and …See details»
MitoRx Therapeutics Announces Close of Seed Extension …
Dec 13, 2023 · OXFORD, United Kingdom, Dec. 13, 2023 (GLOBE NEWSWIRE) -- MitoRx Therapeutics (MitoRx), a biotechnology company developing novel therapeutics that reverse …See details»
MitoRx Therapeutics
Dec 13, 2023 · MitoRx Therapeutics (MitoRx), a biotechnology company developing novel therapeutics that reverse mitochondrial dysfunction to arrest the progression of degenerative …See details»
MitoRx - Oxford Technology (S)EIS Fund Invests in Seed Round
Apr 25, 2022 · MitoRx Therapeutics (MitoRx), a biotechnology company developing novel therapeutics to reverse mitochondrial dysfunction and arrest the progression of degenerative …See details»
Clinical and Scientific Advisory Board - MitoRx …
MitoRx's Clinical and Scientific Advisory Board (SAB) is being developed for scientific review of our R&D activities and to help senior management make the best scientific and clinical development decisions.See details»
MitoRx Therapeutics Strengthens Leadership with Key ... - BioSpace
Oct 3, 2024 · At MitoRx our mission is to become the leading global developer of medicines arresting the progression of degenerative diseases driven by mitochondrial dysfunction. We …See details»
MitoRx Therapeutics Announces Close of Seed Extension
Dec 13, 2023 · OXFORD, United Kingdom, Dec. 13, 2023 (GLOBE NEWSWIRE) -- MitoRx Therapeutics (MitoRx), a biotechnology company developing novel therapeutics that reverse …See details»
Halting the Progress of Degenerative Diseases - Science Angel …
Apr 26, 2022 · MitoRx Therapeutics (MitoRx), is a platform-biotechnology company developing novel therapeutics that reverse mitochondrial dysfunction to arrest the progression of …See details»
MitoRx Therapeutics Announces Seed Financing to Advance its ...
OXFORD, England, April 25, 2022 /PRNewswire/ -- MitoRx Therapeutics (MitoRx), a biotechnology company developing novel therapeutics that reverse mitochondrial dysfunction …See details»
Press Room - MitoRx Therapeutics
Apr 25, 2022 · Check-in here for updates and press releases for MitoRx Therapeutics. Reversing mitochondrial dysfunction to arrest decline in muscular dystrophy and neurodegeneration.See details»
MitoRx Therapeutics Announces Seed Financing to Advance its
Oxford, England, 25 April 2022 - MitoRx Therapeutics (MitoRx), a biotechnology company developing novel therapeutics that reverse mitochondrial dysfunction to arrest the progression …See details»
MitoRx Therapeutics Announces Seed Financing to Advance its
Oxford, England, 25 April 2022 - MitoRx Therapeutics (MitoRx), a biotechnology company developing novel therapeutics that reverse mitochondrial dysfunction to arrest the progression …See details»
MitoRx Therapeutics secures investment from Science Angel …
Apr 26, 2022 · Science Angel Syndicate (SAS) was launched in September 2021 to support investments into frontier scientific discoveries that impact society on a global scale. Leveraging …See details»